Medical Mycology

1
MEDICAL MYCOLOGY Arthur F. Di Salvo MD Reno
Nevada
2
(No Transcript)
3
(No Transcript)
4
Medical Mycology Outline

• HOUR SUBJECT
• Introduction Actinomycetes
• Yeasts Dermatophytes
• Filamentous Fungi Dimorphic Fungi
• Dimorphic Fungi
• Opportunistic Fungi

5
OBJECTIVES

• To impart sufficient basic science of the
  medically important fungi to assist you in
  diagnosing mycotic diseases.
• To impart sufficient clinical knowledge
• to raise your index of suspicion for mycotic
  diseases.

6

• What is SAID is not HEARD
• What is HEARD is not UNDERSTOOD
• What is UNDERSTOOD is not RETAINED
• What is RETAINED is not IMPLEMENTED

7

• ASK QUESTIONS ANYTIME

8
INTRODUCTION
9
(No Transcript)
10
(No Transcript)
11
(No Transcript)
12
(No Transcript)
13
Fairy Ring Mushrooms
14
What is Mycology
15
Mycology is the study of

• Beer
• Wine
• Bread
• Cheese
• Gourmet mushrooms
• Environmental toxins
• Biodegradation
• Disease

16
(No Transcript)
17
(No Transcript)
18
(No Transcript)
19
(No Transcript)
20

21
(No Transcript)
22
(No Transcript)
23
BIOREMEDIATION

• Oil spills
• Cyanide in mining operations
• Dioxins and pesticides
• Produce organic acids sugars
• Other commercial products

24
(No Transcript)
25
A. Classification
26
What is a Fungus

• Eukaryotic a true nucleus
• Do not contain chlorophyll
• Have cell walls
• Produce filamentous structures
• Produce spores

27
Species of Fungi

• 100000 200000 species
• About 300 pathogenic for man

28
Kingdom Fungi Eukaryocytes

• Ascomycota
• Basidiomycota
• Zygomycota
• Mitosporic Fungi
• (Fungi Imperfecti)

29
 
30
 
31
SIZE COMPARISON OF PATHOGENS
32
Actinomyces(True Bacteria)

• Tradition
• Clinical infection resembles mycoses
• Actinomyces grow on mycotic media
• Actinomyces grow slowly (24-48 h)
• Gross colonies resemble fungi
• (roughheaped short aerial filaments)
• Resemble mycelia microscopically with branched
  mycelia in tissue and smears.

33
HANDOUT

• Page 2

34
What is Medical Mycology
35
MYCOTIC DISEASES(Four Types)

• Hypersensitivity
• Allergy
• Mycotoxicosis
• Production of toxin
• Mycetismus (mushroom poisoning)
• Pre-formed toxin
• Infection

36
Hypersensitivity

• FARMERS LUNG Moldy hay
• MALT WORKERS DISEASE Moldy barley
• CHEESE WASHERS LUNG Moldy cheese
• WOOD TRIMMERS DISEASE Moldy wood

37
(No Transcript)
38
PATHOGENIC FUNGI

• NORMAL HOST
• Systemic pathogens - 25 species
• Cutaneous pathogens - 33 species
• Subcutaneous pathogens - 10 species
• IMMUNOCOMPROMISED HOST
• Opportunistic fungi - 300 species

39
PARASITIC STATE

• Increased metabolic state
• Modified metabolic pathways
• Modified cell wall structure
• Carbohydrate content
• Lipid structure
• RNA aggregates

40
PATHOGENICITY OF FUNGI

• Thermotolerance
• Ability to survive in tissue environment
• Ability to withstand host defenses

41
REVIVED INTEREST IN MYCOLOGY

• Increased frequency of mycotic diseases
• Increased awareness by physicians
• Better trained laboratory personnel
• More invasive procedures used on patients
• Increased use of immunosuppressive drugs
• Increase in immunosuppressive disease
• 7. Better laboratory diagnostic tools

42
(No Transcript)
43
B. MORPHOLOGY
44
MORPHOLGY

• Yeasts
• Hyphae (filamentous fungi mycelium)
• Septate
• Coenocytic (non-septate)
• Dimorphic
• Yeast
• Mycelium

45
(No Transcript)
46
(No Transcript)
47
(No Transcript)
48
Dimorphic Fungi

• Yeast Form
• Parasitic form
• Tissue form
• Cultured at 37 C
• Mycelial Form
• Saprophytic form
• Cultured at 25 C

49
SPORES

• SEXUAL
• ASEXUAL
• Arthrospore
• Blastospore
• Chamydospore
• Conidia
• Microconidia
• Macroconidia

50

51
(No Transcript)
52
(No Transcript)
53
By their fruits ye shall know them

• Mathew 720

54
(No Transcript)
55
(No Transcript)
56
EPIDEMIOLOGY

• PAGE 3

57
C. EPIDEMIOLOGY
58

• MOST MYCOTIC AGENTS
• ARE SOIL SAPRPHYTES

59
ECOLOGICAL ASSOCIATION

• PATHOGEN HUMAN SOIL
• _________________________________________
• Blastomyces dermatitidis 1898 1964
• Cryptococcus neoformans 1894 1951
• Coccidioides immitis 1900 1932
• Histoplasma capsulatum 1934 1949

60
Mycotic Diseases Are NOTContagious
61
(No Transcript)
62
ESTABLISHMENT OF INFECTION WITH A MYCOTIC AGENT
DEPENDS ON

• Inoculum size
• Resistance of the host

63
(No Transcript)
64
THE CLINICIAN MUST DISTINGUISH BETWEEN

• COLONIZATION
• FUNGEMIA
• INFECTION

65
PORTAL OF ENTRY
MOUTH
RESPIRATORY TRACT
EYE

• SKIN
• HAIR
• NAILS
• RESPIRATORY TRACT
• GASTROINTESTINAL TRACT
• URINARY TRACT

SKIN
UROGENITAL TRACT
ANUS
66
COLONIZATION
MOUTH
RESPIRATORY TRACT
EYE
Multiplication of an organism at a given site
without harm to the host
SKIN
UROGENITAL TRACT
ANUS
67
INFECTION
MOUTH
RESPIRATORY TRACT
EYE
Invasion and multiplication of organisms in body
tissue resulting in local cellular injury.
SKIN
UROGENITAL TRACT
ANUS
68
GEOGRAPHIC DISTRIBUTION

• The present ease and frequency of world-wide
  travel make it more likely that physicians in the
  United States will be confronted with a variety
  of unfamiliar mycoses acquired in distant parts
  of the country or of the world.

69
Endemic Mycoses

• Those fungus infections with a limited geographic
  distribution. They are all caused by dimorphic
  fungi

70
PATIENT HISTORY

• Medical
• Travel
• Occupation
• Avocation

71
(No Transcript)
72
(No Transcript)
73
D. DIAGNOSIS
74
Diagnosis1. Wet Mount2. Skin
test3. Serology4. Fluorescent antibody5.
Biopsy and histopathology6. Culture7. DNA
probes
75
Diagnosis1. Wet Mount2. Skin
test3. Serology4. Fluorescent antibody5.
Biopsy and histopathology6. Culture7. DNA
probes
76
DIRECT MICROSCOPIC OBSERVATION

• 10 KOH
• Gentle Heat

77
(No Transcript)
78
KOH Wet Mount
79
Diagnosis1. Wet Mount2. Skin
test3. Serology4. Fluorescent antibody5.
Biopsy and histopathology6. Culture7. DNA probes
80
SKIN TESTING(DERMAL HYPERSENSTIVITY)

• Use is limited to
• Determine cellular defense mechanisms
• Epidemiologic studies

81
(No Transcript)
82
Diagnosis1. Wet Mount2. Skin
test3. Serology4. Fluorescent antibody5.
Biopsy and histopathology6. Culture7. DNA probes
83
FUNGI ARE POOR ANTIGENS
84
FUNGAL SEROLOGYANTIBODIES

• Latex Agglutination IgM
• Immunodiffusion IgG
• Complement Fixation IgG

85
(No Transcript)
86
Most serological tests for fungi measure
antibody. Newer tests to measure antigen are now
being developed

• ANTIGEN DETECTION PRESENTLY AVAILABLE
• Cryptococcosis
• Histoplasmosis
• Aspergillosis

87
Diagnosis1. Wet Mount2. Skin
test3. Serology4. Fluorescent antibody5.
Biopsy and histopathology6. Culture7. DNA probes
88
DIRECT FLUORESCENT ANTIBODYCAN BE APPLIED TO

• HISTOLOGIC SECTIONS
• CULTURE
• Viable organisms
• Non-viable organisms

89
(No Transcript)
90
Diagnosis1. Wet Mount2. Skin
test3. Serology4. Fluorescent antibody5.
Biopsy and histopathology6. Culture7. DNA probe
91
INFLAMMATORY REACTION

• Normal host
• Pyogenic
• Granulomatous
• Immunodeficient host
• Necrosis

92
Polymorphic Nuclear Leukocytes
93
Giant Cell
94
GMS
95
Diagnosis1. Wet Mount2. Skin
test3. Serology4. Fluorescent antibody5.
Biopsy and histopathology6. Culture7. DNA probes
96
ISOLATION MEDIA

• SABOURAUD DEXTROSE AGAR
• (pH 5.6)
• Plain
• With antibiotics
• With cycloheximide

97
INCUBATION TEMPERATURE

• 37 C - Body temperature
• 25 C - Room temperature

98
Diagnosis1. Wet Mount2. Skin
test3. Serology4. Fluorescent antibody5.
Biopsy and histopathology6. Culture7. DNA probes
99
DNA Probes

• Rapid (1-2 Hours)
• Species specific
• Expensive

100
E. TREATMENT
101
THERAPY

• Because they are eukaryotic fungi are
  biochemically similar to the human host.
  Therefore it is difficult to develop
  chemotherapeutic agents that will destroy the
  invading fungus without harming the patient.

102
A BASIC TENET OF PATHOLGY

• A CAUSE OF IRREVERSIBLE CELL INJURY IS CELL
  MEMBRANE DAMAGE.

103
IN FUNGAL THERAPY

• We attempt to induce cell injury by causing
  the cell membrane of the fungus to become
  permeable.

104
PROBLEM

• Finding an agent that will selectively injure
  fungal cell walls without damaging the host cell.

105
ALL EUKARYOTIC CELLS CONTAIN STEROLS

• Mammalian cells cholesterol
• Fungal cells - ergosterol

106
(No Transcript)
107
PRIMARY ANTI-FUNGAL AGENTS

• Polyene derivatives
• Amphotericin B
• Nystatin
• Azoles
• Ketoconazole
• Fluconazole
• Itraconazole
• Voriconazole
• Posaconazole

108
AMPHOTERICIN BMechanism of Action

• Amphotericin B binds to sterols
• Ergosterol is a constituent of the fungal cell
  wall
• AMB has a greater avidity for ergosterol than for
  the cholesterol in the human cell wall
• Binding to the fungal cell wall alters the
  permeability and the intracellular contents leak

109
AMPHOTERICIN BDisadvantages

• Intravenous administration
• Thrombophlebitis
• Nephrotoxic
• Fever
• Chills
• Anemia
• Long term administration

110
Azoles

• There are a few rare serious side effects from
  Itraconazole and Fluconazole

111
PRIMARY ANTI-FUNGAL AGENTS

• 3. Griseofulvin
• 4. 5-fluorocytosine (5-FC)
• 5. Allylamines
• -Terbinafine (Lamasil)
• 6. Echinocandins
• - Caspofungin

112
Griseofulvin

• A slow acting drug used for skin and nail
  infections. It accumulates in the stratum
  corneum and prevent hyphal penetration through
  these layers

113
5-fluorocytosine(5-FC)

• Interferes With RNA Synthesis

114
MECHANISMS OF ACTION

• Polyenes
• Azoles
• Griseofulvin
• 5 - FC

• Ergosterol in cell membrane
• Interfere with ergosterol synthesis
• Forms a barrier to fungal growth
• Inhibits RNA synthesis

115
(No Transcript)
116
(No Transcript)
117
F. Clinical Classification of Mycoses

• Cutaneous
• Subcutaneous
• Systemic
• Opportunistic

118
Cutaneous Mycoses

• Skin hair and nails
• Rarely invade deeper tissue
• Dermatophytes

119
Subcutaneous Mycoses

• Confined to subcutaneous tissue and rarely spread
  systemically. The causative agents are soil
  organisms introduced into the extremities by
  trauma

120
Systemic Mycoses

• Involve skin and deep viscera
• May become widely disseminated
• Predilection for specific organs

121
OPPORTUNISTIC FUNGI

• Ubiquitous saprophytes and occasional pathogens
  that invade the tissues of those patients who
  have
• Predisposing diseases
• Diabetes cancer leukemia etc.
• Predisposing conditions
• Agammaglobulinemia steroid or
  antibiotic therapy.

122
Medical Mycology Iceberg
123
THE ESSENTIAL ELEMENT OF DIAGNOSIS IS

• A HIGH INDEX OF SUSPICION !

124
End of Introduction